Neoadjuvant/adjuvant pembrolizumab and surgery + cesium-131 in recurrent HNSCC: A multicenter phase I/IIb trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System A total of 519 patients with esophageal cancer were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results